Hostname: page-component-7b9c58cd5d-f9bf7 Total loading time: 0 Render date: 2025-03-16T05:30:55.525Z Has data issue: false hasContentIssue false

Public-Private Partnerships in Drug Development for Underdeveloped Countries: An Interview with Craig Wheeler, President of Chiron's Biopharmaceutical Division

Published online by Cambridge University Press:  07 August 2003

Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In an effort to create a mechanism for addressing a critical need of providing medicines for economically developing countries, the Chiron Corporation and the Global Alliance for TB Drug Development have entered into an innovative public-private partnership. In the following interview, Craig Wheeler discusses the origins and nature of this agreement that could set a pattern for how corporations and nonprofit organizations can work together in drug development.

Type
SPECIAL SECTION: BIOETHICS AND BIOTECHNOLOGY
Copyright
© 2003 Cambridge University Press